ConductScience.org, home

Paper39293153

An effective vaccine against influenza A virus based on the matrix protein 2 (M2).

Zuckermann FA and 6 others. Vet Microbiol, 2024. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. An effective vaccine against influenza A virus based on the matrix protein 2 (M2). Papers, record 39293153. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39293153

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An effective vaccine against influenza A virus based on the matrix protein 2 (M2).
PubMed
Journal
Vet Microbiol
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.71, provisional
iCite
Revised in PubMed
2026-01-27
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zuckermann FAFederico A
2Grinkova YVYelena V
3Husmann RJRobert J
4Pires-Alves MMelissa
5Storms SSuzanna
6Chen WYWei-Yu
7Sligar SGStephen G

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Viral Matrix ProteinsMajor topic
Influenza VaccinesMajor topic
Orthomyxoviridae InfectionsMajor topic
Antibodies, ViralMajor topic
Influenza A Virus, H3N2 SubtypeMajor topic
Adjuvants, ImmunologicMajor topic
Swine DiseasesMajor topic
Animals
Swine
Influenza A virus
Immunoglobulin G
Injections, Intramuscular
Nanostructures
Viroporin Proteins

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R35 GM118145NIGMS NIH HHSUnited StatesR35GM118145PubMed

Source NIH RePORTER

Download CSV of grants

References82

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129506129A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.J Infect Dis2018https://conductscience.org/library/papers/29506129PubMed
233195504Influenza A Virus in Swine: Epidemiology, Challenges and Vaccination Strategies.Front Vet Sci2020https://conductscience.org/library/papers/33195504PubMed
319828606Nanodisc-incorporated hemagglutinin provides protective immunity against influenza virus infection.J Virol2010https://conductscience.org/library/papers/19828606PubMed
431988203Swine Influenza A Viruses and the Tangled Relationship with Humans.Cold Spring Harb Perspect Med2021https://conductscience.org/library/papers/31988203PubMed
533165998Nanodiscs: A toolkit for membrane protein science.Protein Sci2021https://conductscience.org/library/papers/33165998PubMed
627273631Nanodiscs for structural and functional studies of membrane proteins.Nat Struct Mol Biol2016https://conductscience.org/library/papers/27273631PubMed
717150104Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2.Virol J2006https://conductscience.org/library/papers/17150104PubMed
81989386Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel.Virology1991https://conductscience.org/library/papers/1989386PubMed
934071367Animal Models for Influenza Research: Strengths and Weaknesses.Viruses2021https://conductscience.org/library/papers/34071367PubMed
1033328212Simultaneous Aerosol and Intramuscular Immunization with Influenza Vaccine Induces Powerful Protective Local T Cell and Systemic Antibody Immune Responses in Pigs.J Immunol2021https://conductscience.org/library/papers/33328212PubMed
1127653543M2-based influenza vaccines: recent advances and clinical potential.Expert Rev Vaccines2017https://conductscience.org/library/papers/27653543PubMed
1217719187The antibody responses to swine influenza virus (SIV) recombinant matrix 1 (rM1), matrix 2 (M2), and hemagglutinin (HA) proteins in pigs with different SIV exposure.Vet Microbiol2008https://conductscience.org/library/papers/17719187PubMed
1319203846Characterization of an influenza A virus isolated from pigs during an outbreak of respiratory disease in swine and people during a county fair in the United States.Vet Microbiol2009https://conductscience.org/library/papers/19203846PubMed
1426557805Mechanisms of Cross-protection by Influenza Virus M2-based Vaccines.Immune Netw2015https://conductscience.org/library/papers/26557805PubMed
1533603740Magnitude and Kinetics of T Cell and Antibody Responses During H1N1pdm09 Infection in Inbred Babraham Pigs and Outbred Pigs.Front Immunol2020https://conductscience.org/library/papers/33603740PubMed
1637782856From Snoot to Tail: A Brief Review of Influenza Virus Infection and Immunity in Pigs.J Immunol2023https://conductscience.org/library/papers/37782856PubMed
1721419164Intranasal delivery of whole cell lysate of Mycobacterium tuberculosis induces protective immune responses to a modified live porcine reproductive and respiratory syndrome virus vaccine in pigs.Vaccine2011https://conductscience.org/library/papers/21419164PubMed
1812124449Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus.J Gen Virol2002https://conductscience.org/library/papers/12124449PubMed
1911182501Response of porcine peripheral blood mononuclear cells to CpG-containing oligodeoxynucleotides.Vet Microbiol2001https://conductscience.org/library/papers/11182501PubMed
2033648602Current and prospective control strategies of influenza A virus in swine.Porcine Health Manag2021https://conductscience.org/library/papers/33648602PubMed

See all 82 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42156695The Nanodisc System for Investigating Protein-Lipid Interactions.Methods Mol Biol2026https://conductscience.org/library/papers/42156695PubMed
40891825Viroporins: emerging viral infection mechanisms and therapeutic targets.J Virol2025https://conductscience.org/library/papers/40891825PubMed
39835123A gram-positive enhancer matrix particles vaccine displaying swine influenza virus hemagglutinin protects mice against lethal H1N1 viral challenge.Front Immunol2024https://conductscience.org/library/papers/39835123PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39293153

GET https://conductscience.org/api/papers/v1/39293153/references?page=2